Follow
Jun Luo
Jun Luo
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ...
New England Journal of Medicine 371 (11), 1028-1038, 2014
27862014
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ...
Cancer research 69 (1), 16-22, 2009
12982009
α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer
J Luo, S Zha, WR Gage, TA Dunn, JL Hicks, CJ Bennett, CM Ewing, ...
Cancer research 62 (8), 2220-2226, 2002
8152002
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
W Liu, S Laitinen, S Khan, M Vihinen, J Kowalski, G Yu, L Chen, ...
Nature medicine 15 (5), 559-565, 2009
7402009
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
W Liu, S Laitinen, S Khan, M Vihinen, J Kowalski, G Yu, L Chen, ...
Nature medicine 15 (5), 559-565, 2009
7402009
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
W Liu, S Laitinen, S Khan, M Vihinen, J Kowalski, G Yu, L Chen, ...
Nature medicine 15 (5), 559-565, 2009
7402009
Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer
ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, M Nakazawa, R Nadal, ...
JAMA oncology 1 (5), 582-591, 2015
6732015
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling
J Luo, DJ Duggan, Y Chen, J Sauvageot, CM Ewing, ML Bittner, JM Trent, ...
Cancer research 61 (12), 4683-4688, 2001
6662001
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer
R Hu, C Lu, EA Mostaghel, S Yegnasubramanian, M Gurel, C Tannahill, ...
Cancer research 72 (14), 3457-3462, 2012
6482012
Breaking the scaling relationship via thermally stable Pt/Cu single atom alloys for catalytic dehydrogenation
G Sun, ZJ Zhao, R Mu, S Zha, L Li, S Chen, K Zang, J Luo, Z Li, SC Purdy, ...
Nature Communications 9 (1), 4454, 2018
4952018
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
B Gurel, T Iwata, CM Koh, RB Jenkins, F Lan, C Van Dang, JL Hicks, ...
Modern pathology 21 (9), 1156-1167, 2008
4892008
miR-21: an androgen receptor–regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth
J Ribas, X Ni, M Haffner, EA Wentzel, AH Salmasi, WH Chowdhury, ...
Cancer research 69 (18), 7165-7169, 2009
4872009
Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with …
ES Antonarakis, C Lu, B Luber, H Wang, Y Chen, Y Zhu, JL Silberstein, ...
Journal of Clinical Oncology 35 (19), 2149, 2017
4292017
Armet, a UPR-upregulated protein, inhibits cell proliferation and ER stress-induced cell death
A Apostolou, Y Shen, Y Liang, J Luo, S Fang
Experimental cell research 314 (13), 2454-2467, 2008
3372008
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
A Sharp, I Coleman, W Yuan, C Sprenger, D Dolling, DN Rodrigues, ...
The Journal of clinical investigation 129 (1), 192-208, 2019
3272019
Human prostate cancer precursors and pathobiology
AM De Marzo, AK Meeker, S Zha, J Luo, M Nakayama, EA Platz, ...
Urology 62 (5), 55-62, 2003
3032003
Prospective multicenter validation of androgen receptor splice variant 7 and hormone therapy resistance in high-risk castration-resistant prostate cancer: the PROPHECY study
AJ Armstrong, S Halabi, J Luo, DM Nanus, P Giannakakou, ...
Journal of Clinical Oncology 37 (13), 1120, 2019
3012019
The mutational landscape of prostate cancer
CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig, H Grönberg, ...
European urology 64 (4), 567-576, 2013
2862013
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases
MJ Aryee, W Liu, JC Engelmann, P Nuhn, M Gurel, MC Haffner, D Esopi, ...
Science translational medicine 5 (169), 169ra10-169ra10, 2013
2752013
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study
MT Schweizer, ES Antonarakis, H Wang, AS Ajiboye, A Spitz, H Cao, ...
Science translational medicine 7 (269), 269ra2-269ra2, 2015
2572015
The system can't perform the operation now. Try again later.
Articles 1–20